由买买提看人间百态

topics

全部话题 - 话题: drugging
首页 上页 1 2 3 4 5 6 7 8 9 10 (共10页)
D***r
发帖数: 7511
s*******d
发帖数: 17566
2
通过邮局寄的一些中药,结果品名写了China Drug。。。
我早上收到传真给我的海关信后就开始狂笑。替it给海关打电话,告诉他们里面实际上
是herbal supplements, 但是海关人说不知道里面的ingredient,不能放。其实这些
德成行都有卖的,价格没差多少。
o********e
发帖数: 474
3
来自主题: PsychoAnalysis版 - anyone know antipsychosis drugs?
I may need to take antipsychosis drug for off label usage (I dont have
psycho disease.)
I got prescription for Abilify I am worried about the side effects. thanks.
b********s
发帖数: 6928
4
【 以下文字转载自 Tennis 讨论区 】
发信人: matador (matador), 信区: Tennis
标 题: Re: 这种时候抓紧时间take drug
发信站: BBS 未名空间站 (Mon Sep 13 18:34:10 2010, 美东)
会让喝水的
j********0
发帖数: 73
5
Molecular dynamics, drug design, force fields...
本广告长期有效^_^ 欢迎站内联系
祝大家新年快乐!
M********t
发帖数: 5032
6
Linus Torvalds因内核注解标点格式发飙
solidot
teikaei
21小时54分钟前
Linus Torvalds在Linux内核邮件开发者列表上再次发飙,将部分程序员偏爱的代码注
解标点格式称为“脑残”。他强烈反对的注解格式类似:/* This is disgusting drug
-induced * crap, and should die */(具体见下图)
和/* This is also very nasty
* and visually unbalanced */
他个人支持的格式类似:
/* This is a comment */

/*
* This is also a comment, but it can now be cleanly
* split over multiple lines
*/
l*****k
发帖数: 587
7
来自主题: Biology版 - De NOVO drug (peptide) design
because of the nature of my work, I just hear a really exciting news. It
is about drug design that produced peptide with almost identical activity
as the cell surface's natural conjugates(an import hormone). Sorry, I don't
think it is appropriate to reveal more details about it.. The peptide is
much, much easier to produce than the real hormone.
I wonder if we can talk about the prospect of this kind of research, I
personally think it is a revolutionary success, it changed the whole way we
can t
M****e
发帖数: 70
8
来自主题: Biology版 - De NOVO drug (peptide) design
talking about de novo peptide-derived drug design, i have an
idea using biosensor for such investigation. basically, i
would like to assess and evaluate the binding affinity of the
peptide to the known receptor as well as its downstream signaling
transductivity. so i may design two chips (biomembrane-based),
both approapriately covered by the receptors, with one linking
to some biosensor that basically detect the affinity, while the
other coupled to the primary downstream signal transducer while
s***n
发帖数: 9
9
来自主题: Biology版 - Scientists who pioneered arthritis drug
The scientific duo of Ray Goodwin and Craig Smith, who made early
breakthroughs that led to the creation of the arthritis drug Enbrel, has been
split up. Both quietly resigned in the past few weeks, a year after biotech
giant Amgen bought Seattle-based Immunex.
Goodwin and Smith, both 52, said they stayed this long to receive one-year
retention bonuses from Amgen and left with no fanfare other than a beer or two
with close colleagues.
The departures were not a shock — they are the latest in a st
S*******i
发帖数: 149
10
By GARDINER HARRIS
Published: February 19, 2010
Hundreds of people taking Avandia, a controversial diabetes medicine,
needlessly suffer heart attacks and heart failure each month, according
to confidential government reports that recommend the drug be removed
from the market.
The reports, obtained by The New York Times, say that if every diabetic
now taking Avandia were instead given a similar pill named Actos, about
500 heart attacks and 300 cases of heart failure would be averted every
month b
y********e
发帖数: 104
11
http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1444203&p_IsPs=N
An overview on the cyclin-dependent kinase 9-related pathway
Romano, G.
Drugs Fut 2010, 35(1): 59
z****a
发帖数: 1
12
Hi,
Could somebody upload again the article:
http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.x
An overview on the cyclin-dependent kinase 9-related pathway
Romano, G.
Drugs Fut 2010, 35(1): 59
I would urgently need it!
Thanks!
w**********s
发帖数: 72
13
High-Content RNAi-Screening Assay to Identify Modulators of Cholesterol
Accumulation in Niemann-Pick Type C Cells
Assay Drug Dev Technol. 2010 May 14. [Epub ahead of print]
Thanks for your help.
O******e
发帖数: 4845
w******e
发帖数: 1187
15
In fact, what I want to find are papers that: 1. study current drug leads;
2. focus on preclinical trial data. hence the title:)
p*******r
发帖数: 4048
16
来自主题: Biology版 - Eli Lilly Halts Alzheimer's Drug Trial
I don't understand. Naively, can't you just reverse the drug's effects to
cure the disease then? :)

's
in
future
s******y
发帖数: 28562
17
来自主题: Biology版 - Eli Lilly Halts Alzheimer's Drug Trial
我觉得拿这个当drug target在生物原理上就是错误的。
gamma-secretase 虽然直接负责amyloid的成熟/生成,
但是并不是导致amyloid 变性的原因。抑制了它的功能很难说和Alzheimer's
有什么直接的逻辑关系。
而且这个酶在正常细胞里就存在,说明它肯定是有正常生理功能的。
这么广泛的到处去抑制它,不产生不良后果才怪了。
A******y
发帖数: 2041
18
来自主题: Biology版 - Eli Lilly Halts Alzheimer's Drug Trial
I am not really in the field. However, there are tons of evidence showing
the amyloid plaques are either protective or doesn't really cause AD. First
, transgenic mice with tons of plaques don't have any disease phenotype.
Second, drugs destroy plaques in human don't do anything to improve the
outcome for patients. Third, scientists have been looking only at one side
of the amyloid, why happen to the cytosol part that's also cleaved off.
Anyone still fighting for amyloid theory to be even pa
y***i
发帖数: 11639
19
来自主题: Biology版 - Eli Lilly Halts Alzheimer's Drug Trial
家族性的AD的变异一半以上是在r-secretae (Psn)上。而这个酶对amyloid plaque的
影响也非常清楚,所以这个酶和AD显然强烈相关,针对这个酶动手,就致病机理上是最
自然的事情,所以这不是个随便乱蒙的例子。现在没多少drug target比r-secretase更
清楚。也许你的总的论点是有道理的,但具体到这个r-secretae上,我想你举了错误的
例子。
唯一的问题是r-secretae是最重要的Notch pathway上必须酶之一。这个基因一旦彻
底敲除(把卵子mRNA也去掉),基本上什么都发育不出来,流产都免了。在果蝇胚胎发
育时大部分细胞都会变成神经细胞,是CPU级别的pathway。Notch pathway在成人中的
功能不完全清楚,但已经知道的部分也相当重要,比如免疫系统的维持。所以针对r-
secretae的毒性估计就从此而来。

amyloid
过。
plaque
p*****m
发帖数: 7030
20
来自主题: Biology版 - Eli Lilly Halts Alzheimer's Drug Trial
这个还真未必 很多FDA approved drug都不是从mouse做起的 从rat从hamster开始的都
有 如果低等动物真的能用来model disease,完全可以直接上大动物
老鼠谈不上是很好的model organism(如果遗传学的优势可以被更低等的动物替代)

功夫
p*****r
发帖数: 64
21
来自主题: Biology版 - 请教drug screen中的技术问题
最近正在用一个悬浮细胞做high-throughput drug screen.流程很简单,就是把细胞加
在384 plate上,加上药物,3天后收细胞,提RNA,转cDNA,再做qPCR. 但是现在发现收细胞
的时候,仪器在remove medium的时候吸走了很多的细胞,使每个孔细胞数目很不一致,这
样做出来的qPCR variation太大. 目前我用V bottom的plate养细胞,不知道大家有这方
面的经验没有,怎样才能避免第一步remove medium时尽量不影响细胞的数目? 有没有可
能不remove medium,就直接在培养基里直接加lysis buffer,拿到RNA呢? 多谢了 :)
c*****t
发帖数: 198
22
【 以下文字转载自 Chemistry 讨论区 】
发信人: compact (support), 信区: Chemistry
标 题: 搞drug discovery有哪些有名的华人?
发信站: BBS 未名空间站 (Mon Jan 31 14:03:32 2011, 美东)
Thanks.
w******e
发帖数: 1187
23
nature review drug discovery
for everything, check FDA website
l*********1
发帖数: 351
24
据预测2014年,top sale drug 前十名里面会有6个抗体药物.就是不知道这块还能玩点
啥东西出来.学界做抗体工程的lerner,winter退休,剩下的也就3,4个牛组了吧.
g******0
发帖数: 290
25
来自主题: Biology版 - Paper help--Curr Drug Targets
Curr Drug Targets. 2011 Apr 1;12(4):563-78.
Dasatinib: An Anti-Tumour Agent via Src Inhibition.
Gnoni A, Marech I, Silvestris N, Vacca A, Lorusso V.
Thank you in advance.
g*********r
发帖数: 9366
26
问题是我的EC50都差不多, 都是5, 7,8 micromolar,
但是Vmax差别很大, 从百分之八九十到三四十
我想了半天,觉着这两个参数都描述了drug resistance 的一定方面
露怯了,咱没正经学过这部分
b******k
发帖数: 1874
27
Can anyone help check if these 2 articles are subscribed in your institution
??? Thanks very much.
http://www.spandidos-publications.com/ijmm/26/5/673
Curcumin inhibits the proliferation of human hepatocellular carcinoma J5 ce
lls by inducing endoplasmic reticulum stress and mitochondrial dysfunction,
International Journal of Molecular Medicine, 2010, 26(5), Pages: 673-678
http://www.ingentaconnect.com/content/ben/cdt/2011/00000012/000
5
The Targets of Curcumin, Current Drug Targets, 2011, 12(3)... 阅读全帖
C*****h
发帖数: 926
28
来自主题: Biology版 - SiRNA or ShRNA for drug development
You may want to try some ligands that are specific to T cell receptors to
deliver drugs.

function
b*****h
发帖数: 783
29
来自主题: Biology版 - 有了解Biosimilar drug的吗?
和生物技术相关的都算biological drug,抗体阿,细胞因子阿,免疫疗法。。。。今
又生当然是,但是也只有中国才会批准他上市。。。
b*****h
发帖数: 783
30
来自主题: Biology版 - 有了解Biosimilar drug的吗?
和生物技术相关的都算biological drug,抗体阿,细胞因子阿,免疫疗法。。。。今
又生当然是,但是也只有中国才会批准他上市。。。
J****a
发帖数: 553
31
来自主题: Biology版 - 有了解Biosimilar drug的吗?
因为结构和生产工艺复杂,防制会有技术壁垒,所以biosimilar对biologics的竞争威
胁不如generic drugs 对小分子药品的竞争威胁大, 是吗?

biological
p*****m
发帖数: 7030
A******y
发帖数: 2041
33
来自主题: Biology版 - misunderstanding about drug discovery
NIH doesn't fund as much as pre-clinical translation science. There are two
study sections for pre-clincial drug discovery and both are worse scoring
ones of all study sections (i.e. you could still be top 40% with 6 in your
scores).
M*P
发帖数: 6456
34
来自主题: Biology版 - misunderstanding about drug discovery
for complex cancer, I don't see a way of cure with simple drugs even when
you know all the targets.
e****t
发帖数: 971
35
小白我只知道immune therapy, bms的新药是breakthrough of the year by science.
gene therapy是不是新方向?novartis的药针对chimeric antigen receptor好像也是
immune therapy。那gene therapy 和immune therapy 不是一回事吗?
还听说过EGFR epidermal growth factor receptor,这个领域的药是传统意义的
targeted medicine吧?不是immune therapy吧?
cell therapy好像也挺火,有的公司把病人免疫细胞取出来繁殖后再注射回去,按理说
这也是immune therapy一种吧?
cancer drug以后的发展方向是什么?个人拙见是human genome sequencing廉价后使
personalized medicine成为可能。
不好意思,小白我恶补后还是一知半解,望大牛和前辈们不吝赐教
e****t
发帖数: 971
36
多谢解惑!包子奉上
再请问您:最近几年有没有别的oncology drug candidate比较火,或者比较有希望?

society
therapy
f********t
发帖数: 66
37
请问路过的大侠们,有没有心脏电生理,干细胞或药物筛选方面的审稿需要转让?
关键字:
Cardiovascular Disease
Arrhythmia
Cardiac Electrophysiology
Patch Clamp
MEA
Ion channels
Stem Cell
Induced pluripotent stem cell- derived cardiomyocytes (iPSC-CMs)
Cardiotoxicity Screening
Drug Discovery
Pharmacological Analysis
本人西海岸大学薄后,为尝试Eb1A正在寻找审稿机会。如果有大侠愿意转让审稿,不胜
感激!
请站内信联系, 谢谢!
r******k
发帖数: 446
38
这么多文章发在cancer cell 和cancer discovery上。 但是一个drug resistance的通
路被block住了,难道就不会出现新的吗? 这玩意简直是没完没了呀。。。
r******k
发帖数: 446
39
但是这个寿命到底能延长多久? 一些drug resistance动不动几个月就出现了。 难道
花那么多钱就研究一个新药就管几个月?
K******S
发帖数: 10109
40
那也不能不管不治啊,不幸的是抗药性出来后一般都会恶化的更快。
抗药性经典的图片

:但是这个寿命到底能延长多久? 一些drug resistance动不动几个月就出现了。 难道
:花那么多钱就研究一个新药就管几个月?
d***s
发帖数: 1062
41
大家都说药厂的D比R好。
肯定是个大工程,需要医生,研究人员,统计师和RA一起工作来完成。
本人搞生物的,所以对实验部分感兴趣。对antibody-based drug来说,这个D包括些什
么工作?需要什么样的skill?或者说需要做什么方向的PhD?
C*********m
发帖数: 213
42
来自主题: Biology版 - 求Curr Drug Targets 2016一篇
跪谢!请邮 [email protected]/* */
作者:
Marinangeli C, Didier S, Vingtdeux V
文题:
AMPK in Neurodegenerative Diseases: Implications and Therapeutic
Perspectives.
期刊名:
Curr Drug Targets
期刊年份:
2016
卷(期),起止页码:
17(8):890-907
Doi:
10.2174/1573399811666150615150235
全文链接:
http://www.eurekaselect.com/132222/article
数据库名称:
Bentham Science Publishers
q**********0
发帖数: 335
43
有谁参加今年的"The ASM/ESCMID Conference on Drug Development to Meet the
Challenge of Antimicrobial Resistance," 吗? The conference will be held
September 6–8, 2017, at the Boston Park Plaza Hotel in Boston, MA.
I*****l
发帖数: 79
44
I am interested in purchasing a second handed market report:
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug
Discovery
Equipment, Technologies and Companies, 2006-2011
Publication Date January 2007
Please let me know if anyone happen to know where to buy. Many thanks.
S********y
发帖数: 160
45
mass transfer vs momentum transfer. convection enhance mass transfer of drug
delivery. A combinition of both fluid dynamics and bioenginering expertise
sounds great to me.
f*****n
发帖数: 970
46
听起来很creative的方向啊,不知道就业前景如何呢?

drug
expertise
l****e
发帖数: 157
47
来自主题: Chemistry版 - Paper help Journal of Drug Targeting 谢了
http://www.labmeeting.com/paper/29047465/ma-2009-a-novel-recombinant-protein-tat-gfp-kdel-with-dual-function-of-penetrating-cell-membrane-and-locating-at-endoplasm-reticulum
Journal of Drug Targeting
May 2009, Vol. 17, No. 4, Pages 329-333 , DOI 10.1080/10611860802582459
A novel recombinant protein TAT–GFP–KDEL with dual-function of penetrating
cell membrane and locating at endoplasm reticulum
Wei Feng Ma‌1, Hong Yuan Chen‌2, Jun Du‌3, Yi Tan‌4,
Shao Hui Cai‌5
Pls s
A*r
发帖数: 2253
48
Somatostatin receptor-targeted anti-cancer therapy.
Sun LC, Coy DH.
Curr Drug Deliv. 2011 Jan 1;8(1):2-10.
对我很重要的文章,发包子给先帮我找到这篇文章的人。
Email to: g**[email protected]
Thanks.
首页 上页 1 2 3 4 5 6 7 8 9 10 (共10页)